Sherpa Healthcare Partners
Out of Scope
Bio
Sherpa Healthcare Partners Sherpa Healthcare Partners manages $400M+ across funds since 2016, with a cross- border focus linking China, the US, and global healthcare innovation. The team combines pharmaceutical industry experience with venture expertise, investing across biopharma, medical devices, diagnostics, and healthcare services. The fund has been particularly active in cell therapy, gene therapy, and precision medicine. advanced modalities where China's rapidly growing biotech sector is
Industries
BiotechMedTechSynthetic Biology
Stages
Series ASeries B+
Geography
US
Notable investments
- InnoCare Pharma
- GenScript subsidiary